Enzyme Or Microbial Cell Is Immobilized On Or In An Inorganic Carrier Patents (Class 435/176)
  • Patent number: 5468620
    Abstract: Methods of glycosylation analysis are described in which a sample containing one or more specific oligosaccharide(s) (the analyte) is contacted with a surface on which is immobilized a glycosidase specific for the analyte and/or a specific binding partner for a product of the action of a glycosidase on the analyte. The surface may be the active surface of a biosensor, e.g., a biosensor based on the principle of frustrated total reflection.
    Type: Grant
    Filed: November 29, 1993
    Date of Patent: November 21, 1995
    Assignee: Fisons PLC
    Inventors: James O. Molloy, Denise V. Pollard-Knight
  • Patent number: 5460945
    Abstract: The present invention provides in vitro models of the in vivo rolling and arrest of leukocytes along the endothelial cell wall, which are important steps in the migration of leukocytes out of the blood stream and into tissue, as part of the inflammatory response. The in vitro models of the invention are functional under physiologic flow conditions resulting in physiologic shear stresses. In a specific embodiment, for modelling leukocyte rolling, the apparatus of the invention comprises a solid phase surface with rolling mediator molecules present thereon. Such rolling mediators are, for example, selectins and selectin ligands which have binding partners expressed on leukocytes. In another specific embodiment, for modelling leukocyte rolling followed by adhesion/arrest, the apparatus of the invention comprises a solid phase surface with both rolling mediators and integrin binding partners present thereon.
    Type: Grant
    Filed: May 20, 1992
    Date of Patent: October 24, 1995
    Assignee: Center for Blood Research, Inc.
    Inventors: Timothy A. Springer, Michael Lawrence
  • Patent number: 5455174
    Abstract: An organic acid ester of ascorbic acid or erythorbic acid is produced by reacting ascorbic acid or erythorbic acid with an organic acid enol ester in an organic solvent with a solubility of ascorbic acid or erythorbic acid of more than 0.3% at 25.degree. C. in the presence of an active lipase.
    Type: Grant
    Filed: September 7, 1993
    Date of Patent: October 3, 1995
    Assignee: Mitsubishi Rayon Company, Ltd.
    Inventors: Keiichi Sakashita, Shiro Miyamoto, Akihiro Sakimae
  • Patent number: 5453270
    Abstract: There is disclosed a pharmaceutical composition and method for metabolic consumption of calories and weight loss. The pharmaceutical composition is a culture of brown adipose cells, preferably encapsulated in a porous growth matrix, and a semipermeable membrane encapsulating the porous matrix wherein the semipermeable membrane has a molecular weight cutoff of at least 10,000 daltons and, preferably, a lipoprotein lipase embedded therein. Further disclosed is a pharmaceutical composition for metabolizing fatty acids into carbon dioxide, water and heat including a mammalian cell stably transfected with a DNA sequence coding for a mammalian UCP polypeptide, wherein the transfected mammalian cell transcribes and translates UCP polypeptide.
    Type: Grant
    Filed: March 2, 1993
    Date of Patent: September 26, 1995
    Assignee: Hypermetabolic Therapies, Inc.
    Inventor: Nathan Bills
  • Patent number: 5443975
    Abstract: Enzymes, cells and/or cellular organelles are bound to an insoluble sintered expanded clay support matrix for catalyzing transformations of agriculture and industrial residues in soil and in other environments. In one embodiment, an enzyme is absorbed by the sintered expanded clay support matrix and a phenolic monomer is polymerized or copolymerized on the support matrix containing the bound enzyme. In another embodiment, an enzyme different from the enzyme absorbed by the support matrix is combined with the phenolic monomer and a copolymer of enzyme and phenolic monomer is formed on the support matrix containing the bound enzyme. The phenolic monomer is preferably catechol, pyrogallic acid and/or resorcinol.
    Type: Grant
    Filed: December 10, 1992
    Date of Patent: August 22, 1995
    Assignees: Ente Per Le Nuove Technologie, L'Energia E L'Ambiente (ENEA), Consiglio Nazionale Delle Ricerche
    Inventors: Stefano Cervelli, Vincenzo Capuano
  • Patent number: 5441877
    Abstract: A biologically enriched substrate containing organic matter rich in colonies of Cyanophycea(cyano-bacteria, also called blue or green algae) and Bryophytes(moss) is prepared for rapid creation of natural vegetation on bare terrain. More specifically, the substrate contains 20-30% material rich in organic matter, 40-60% synthetic polymer and 10-20% clay material inoculated with a combination of colonies of Cyanophycea and colonies of Bryophytes in the form of protonemas. The material rich in organic matter is preferably black peat, blond sphagnum bog, Briere black, composts, straw, leaves, manure, tree barks, vine shoots, marc of grapes, seaweed, wood chips, saw dust, mushroom grindings, river mud or marsh mud. The clay material is preferably montmorillonite, micaceous or kaolinite clay. The substrate may also contain starch, limestone, phosphate chalk type A, phosphate chalk type B, calcareous marl, slimy sand or polder.
    Type: Grant
    Filed: March 18, 1994
    Date of Patent: August 15, 1995
    Inventors: Michel Chiaffredo, Claude Figureau
  • Patent number: 5432274
    Abstract: Ferricinium or ferricinium-based compounds are useful as blue redox dyes suitable for monitoring various enzymatic oxidation processes. A process for preparing such dyes is proposed which involves complexing ferrocene or its derivative with a cyclodextrin. The resulting yellow inclusion complex, an intermediate of the redox dye, is then oxidized electrochemically or by a reaction with bilirubin oxidase to form blue redox dyes which exhibit absorption peaks at 620 or 650 nm. Both the reduced form and the oxidized form of the dye are water-soluble.
    Type: Grant
    Filed: July 28, 1993
    Date of Patent: July 11, 1995
    Assignee: National Research Council of Canada
    Inventors: John H. T. Luong, Keith B. Male, Shishan Zhao, R. Stephen Brown
  • Patent number: 5419902
    Abstract: This invention relates to a method for inactivating pathogens using the peroxidase enzyme. The peroxidase enzyme is reacted with hydrogen peroxide or a source of hydrogen peroxide and an iodide anion to generate reaction products which are separated from the peroxidase enzyme and then used to inactivate pathogenic organisms.
    Type: Grant
    Filed: July 16, 1993
    Date of Patent: May 30, 1995
    Assignee: Symbollon Corporation
    Inventor: Jack Kessler
  • Patent number: 5416007
    Abstract: Disclosed are methods for increasing the yield of intact target proteins by cleaving fused polypeptides made by recombinant DNA techniques. The fused polypeptides are designed at the DNA level to have a preselected primary cleavage site in a pendant polypeptide fused to a protein of interest. Structural features of the fused polypeptide and cleavage reaction environment are controlled to favor cleavage by a preselected cleavage agent at the primary cleavage site over a second cleavage agent-sensitive amino acid sequence in the target protein. The cleavage reaction is terminated before completion when the ratio of intact target protein to truncated, cleaved target protein is optimized, and the remaining reaction mixture comprising uncleaved fused polypeptide is resubjected to the cleavage agent. The presence of charged organic molecules in the cleavage reaction mixture favors cleavage at the primary cleavage site. The endopeptidase used for cleavage may be immobilized on an insoluble support matrix.
    Type: Grant
    Filed: July 12, 1994
    Date of Patent: May 16, 1995
    Assignee: Creative BioMolecules, Inc.
    Inventors: Marc F. Charette, Roberto Crea, Charles M. Cohen
  • Patent number: 5407818
    Abstract: A biosensor is prepared having a selective detection system containing a biochemical substance such as an enzyme immobilized on an olefinic-unsaturated, epoxyfunctional polysiloxane. Prior to immobilization of the biochemical substance, the polysiloxane is applied as a layer to a carrier and cross-linked by treatment with high-energy radiation. A biochemical substance is reacted with epoxy groups of the cross-linked polysiloxane. Any non-reacted epoxy groups are reacted with a compound containing an amino group, a carboxyl group or an amino group and a carboxyl group to stabilize. After cross-linking and before reacting of the biochemical substance, the cross-linked polysiloxane can be hydrophilized by reacting some of the epoxy groups with a hydrophilic compound containing a reactive group.
    Type: Grant
    Filed: March 22, 1993
    Date of Patent: April 18, 1995
    Assignee: Siemens Aktiengesellschaft
    Inventors: Wolfgang von Gentzkow, Hans-Dieter Feucht, Helmut Formanek, Gerhard Wanner
  • Patent number: 5405766
    Abstract: Enzymes and certain other bioactive substances are immobilized on solid substrates which have sufficient functional groups such as hydroxyl or carboxyl. The bioactive substances are linked to the substrates through spacer compounds having a long open alkyl chain with 7-18 carbon atoms and also through phospholipid intermediates. The spacer compound is chemically linked to the substrate. The phospholipid is covalently linked to the spacer compound. Immobilized bioactive substances of the invention exhibit a marked increase in activity and stability. In a preferred embodiment, immobilized enzymes having a high degree of resistance to thermal inactivation are prepared.
    Type: Grant
    Filed: March 25, 1993
    Date of Patent: April 11, 1995
    Assignee: Her Majesty the Queen in right of Canada, as represented by the Minister of National Defence
    Inventors: Krishna M. R. Kallury, Michael Thompson, William E. Lee
  • Patent number: 5403750
    Abstract: Affinity matrices useful for the chromatography and immobilization of biological materials and the method of preparing and using the same are disclosed. The affinity supports are based on hydrated polyurethane polymers which have been activated to provide a means for covalently attaching a variety of bioaffinity agents. The hydrated polymer matrices are characterized by their biocompatibility and resistance to nonspecific protein adsorption. Preferably, the prepolymers used to prepare the hydrated polymers are isocyanate-capped oxyethylene-based diols or polyols, at least 75% of said diols and polyols having a molecular weight of 7000 to about 30,000.
    Type: Grant
    Filed: April 8, 1991
    Date of Patent: April 4, 1995
    Assignee: W. R. Grace & Co.-Conn.
    Inventors: James A. Braatz, Aaron H. Heifetz
  • Patent number: 5403742
    Abstract: A bioreactor is provided for production of products by biosynthesis or biotransformation using a biofilm of immobilized cells. The bioreactor includes a horizontal cylindrical housing and a central rotatable shaft which extends along the axis of the housing. Connected to the central shaft are one or more screens which are oriented parallel to the shaft, with a small gap between the shaft and the screen. The bioreactor further includes a slidable blade which is mounted onto the shaft, through a set of poles, and which is located at a fixed distance from the screen so that the blade is made to pass over the screen by the force of gravity as the shaft rotates, as by the action of a rotating external magnet. An example of use of the bioreactor is the production of .UPSILON.-decalactone from castor oil using Tyromyces sambuceus.
    Type: Grant
    Filed: September 1, 1993
    Date of Patent: April 4, 1995
    Assignee: Ramot University Authority Ltd.
    Inventor: Amihay Freeman
  • Patent number: 5401647
    Abstract: Disclosed is a method of preparing limulus amoebocyte lysate substantially free from factor G which comprises bringing limulus amoebocyte lysate into contact with an insoluble carrier on which a (1.fwdarw.3)-.beta.-D-glucoside structural portion represented by the following formula [I] produced by depolymerizing and/or fractionating a carbohydrate chain is immobilized: ##STR1## wherein n represents an integer of 2 to 370.
    Type: Grant
    Filed: May 27, 1992
    Date of Patent: March 28, 1995
    Assignee: Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation)
    Inventors: Shigenori Tanaka, Jun Aketagawa, Yuko Shibata
  • Patent number: 5397759
    Abstract: Hollow porous microspheres of uniform diameter and of uniform wall thickness are disclosed. The walls of the hollow microspheres comprise sintered together particles which define interconnecting voids within the walls and a single central cavity in the interior of the microspheres and inner and outer microsphere wall surfaces. The interconnecting voids are continuous and extend from the outer wall surface to the inner wall surface. The walls have uniform void content and the interconnecting voids are uniformly distributed in the walls of the hollow microspheres and the walls of the hollow microspheres are free of latent solid or liquid blowing gas materials and are substantially free of relatively thinned wall portions and bubbles. The hollow porous microspheres include microspheres in which the interconnecting voids have been closed and sealed.
    Type: Grant
    Filed: July 9, 1992
    Date of Patent: March 14, 1995
    Inventor: Leonard B. Torobin
  • Patent number: 5397755
    Abstract: A bioremediation support for the support of microorganisms used in the biotreatment of an aqueous waste stream or contaminated vapor is made of a low-density siliceous glassy material. This material has a cellular or frothy texture, large pores of greater than 1,000 Anstrom units in diameter dispersed throughout the material, a high macropore volume in pores of greater than 1,000 .ANG. of more than 0.3 cc/cc and a BET surface area of greater than 10 m.sup.2 /g. A preferred material is pumice.
    Type: Grant
    Filed: June 29, 1993
    Date of Patent: March 14, 1995
    Assignee: W. R. Grace & Co.-Conn.
    Inventors: Frederick J. Parker, Awdhoot V. Kerkar, Rasto Brezny
  • Patent number: 5395808
    Abstract: Porous bodies are produced which are suitable for use as supports for catalysts, including living cells, such as bacteria. The bodies have a significantly large average pore diameter of about 0.5 to 100 microns, (i.e. 5,000 to 1,000,000 .ANG.) and a total pore volume of about 0.1 to 1.5 cc/g with the large pores contributing a pore volume of from about 0.1 to 1.0 cc/g. The bodies are made by preparing a mixture of ultimate particles of bound clay, one or more optional ingredients such as inorganic binders, extrusion or forming aids, burnout agents, or a forming liquid, such as water. In a preferred embodiment, the ultimate particles are formed by spray drying.
    Type: Grant
    Filed: December 21, 1992
    Date of Patent: March 7, 1995
    Assignee: W. R. Grace & Co.-Conn.
    Inventors: James G. Miller, Michael J. Wax, Richard F. Wormsbecher
  • Patent number: 5391463
    Abstract: Irradiating, with ultraviolet light, surfaces which contain thiol groups, epoxy groups, or vicinal diol groups, results in surfaces which exhibit a reduced adsorption of biomolecules. In the case of surfaces having thiol groups such irradiation also results in a reduced capacity for the bonding of heterobifunctional crosslinking reagents. Such irradiation may be carried out in a patternwise fashion to obtain patterned surfaces.
    Type: Grant
    Filed: April 25, 1991
    Date of Patent: February 21, 1995
    Assignees: The United States of America as represented by the Secretary of the Navy, Geo-Centers, Inc.
    Inventors: Frances S. Ligler, Suresh Bhatia, Lisa C. Shriver-Lake, Jacque Georger, Jeff Calvert, Charles Dulcey
  • Patent number: 5389115
    Abstract: Pills or pellets containing genetic material and inert carrier material, characterized in that the inert carrier material forms the core of the pills or pellets, while the genetic material is distributed in a multitude around the core, adhering to that core in an adhesive layer and method for the preparation of pills or pellets containing genetic material and inert carrier material, characterized in that onto cores formed from inert carrier material a fluid adhesive containing genetic material is applied, if necessary diluted with other material, in a quantity corresponding with at least two genetic material units per present inert core, making up the adhesive layer, or that the genetic material is first mixed with a powdery adhesive, if necessary diluted with other powdery material in a quantity so that per present core at least two genetic material units are available, after which the mixture of genetic material and at least adhesive, and simultaneous addition of fluid to form the adhesive layer, is applied
    Type: Grant
    Filed: November 17, 1992
    Date of Patent: February 14, 1995
    Assignee: Incotec B.V.
    Inventor: Robert J. Legro
  • Patent number: 5389534
    Abstract: A biosensor is prepared having a selective detection system containing a biochemical substance such as an enzyme immobilized by reaction with epoxy groups of an olefinic-unsaturated, epoxyfunctional polyether. Prior to immobilization, the polyether is applied to a carrier and crosslinked by treatment with high-energy radiation or peroxide to form a layer. After reacting the biochemical substance with epoxy groups, non-reacted epoxy groups are reacted with a compound containing an amino group and/or a carboxyl group such as an amino acid. Before immobilizing of the biochemical substance and after crosslinking, the polyether may be hydrophilized by reacting some of the epoxy groups with a hydrophilic compound such as an amino acid.
    Type: Grant
    Filed: March 22, 1993
    Date of Patent: February 14, 1995
    Assignee: Siemens Aktiengesellschaft
    Inventors: Wolfgang von Gentzkow, Hans-Dieter Feucht
  • Patent number: 5389533
    Abstract: Biochemical substances such as enzymes are immobilized by reaction with epoxy groups of an olefinic-unsaturated, epoxyfunctional polyether. Prior to immobilization, the polyether is applied to a carrier and crosslinked by treatment with high-energy radiation or peroxide to form a layer. After reacting the biochemical substance with epoxy groups, non-reacted epoxy groups are reacted with a compound containing an amino group and/or a carboxyl group such as an amino acid. Before immobilizing of the biochemical substance and after crosslinking, the polyether may be hydrophilized by reacting some of the epoxy groups with a hydrophilic compound such as an amino acid.
    Type: Grant
    Filed: March 22, 1993
    Date of Patent: February 14, 1995
    Assignee: Siemens Aktiengesellschaft
    Inventors: Wolfgang von Gentzkow, Hans-Dieter Feucht
  • Patent number: 5369017
    Abstract: A process for the synthesis of a glycopeptide using a solid phase matrix is disclosed. The matrix is compatible with aqueous and organic solvents and is comprised of a silica-based solid support to which is linked a two-part spacer group having a chain length of about 12 to about 40 methylene groups. The first part of the spacer is covalently bonded to the silica-based support and has a length of about 3 to about 10 methylene groups. The second spacer part is covalently bonded to the first part of the spacer and comprises the distal end of the two part spacer. The second part is soluble as a free molecule in each of water, dimethylformamide and dichloromethane and has a terminal amine or hydroxyl group to which the C-terminal residue of the peptide portion of the glycopeptide chain is bonded.
    Type: Grant
    Filed: February 4, 1994
    Date of Patent: November 29, 1994
    Assignee: The Scripps Research Institute
    Inventors: Chi-Huey Wong, Matthias Schuster
  • Patent number: 5356780
    Abstract: The invention relates to a competitive binding assay technique for substances (e.g. small molecules having no antigenic determinant) which can serve as substrates for coenzyme-requiring enzymes. The technique involves contacting a liquid sample with an assay system including (i) a substrate analogue and (ii) a moiety capable of binding specifically to the substrate without catalyzing the conversion of substrate to product. The substrate analogue is a substance capable of binding to said moiety competitively with any of the substrate present in the sample. The presence or amount of the substrate is determined by monitoring the extent to which there are formed or remain complexes between the moiety and substrate or substrate analogue.
    Type: Grant
    Filed: March 17, 1993
    Date of Patent: October 18, 1994
    Assignee: Applied Research Systems Holding N.V.
    Inventors: Grenville A. Robinson, John G. Hurrell
  • Patent number: 5354652
    Abstract: Lead assays using .delta. aminolevulinic acid dehydratase are disclosed.
    Type: Grant
    Filed: May 3, 1993
    Date of Patent: October 11, 1994
    Assignee: The University of Maryland at Baltimore
    Inventor: Ellen K. Silbergeld
  • Patent number: 5342768
    Abstract: A particulate immobilized microbial lipase is prepared by adsorption of lipase to macroporous inorganic carrier particles having specific characteristics. The carrier particles contain at least 65% silica or silicates, an excess of 90% particles having a size between 100 and 1000 .mu.m and an excess of 80% pores exhibiting a diameter of between 12 and 45 times the diameter of a lipase molecule. The lipase is adsorbed to the carrier particles by contacting the particles with an aqueous solution of lipase and drying the particles to a water content between 1 and 20%. The lipase is preferably a thermostable lipase from a Humicola species, Candida antarctica or Rhizomucor miehei. The particulate immobilized lipase is cheap to produce, exhibits a high specific activity, and can be used for interesterification of fats, hydrolysis of fats or synthesis of fatty acid esters.
    Type: Grant
    Filed: April 24, 1991
    Date of Patent: August 30, 1994
    Assignee: Novo Nordisk A/S
    Inventors: Sven Pedersen, Tomas T. Hansen
  • Patent number: 5342692
    Abstract: Novel articles are provided comprising at least one polymerized surfactant layer and at least one protein layer specifically bound to the surfactant layer. Depending upon the nature of the preparation of the layers, the layers may be formed as a plurality of substantially parallel layers, filaments, tubes, helices or other complex assembly. The articles may be used for improved determination of protein structure, electronic devices, enzyme reactors and in biosensors. Improved methods are provided for electron microscopic analysis of proteins.
    Type: Grant
    Filed: March 30, 1993
    Date of Patent: August 30, 1994
    Assignee: Biocircuits Corporation
    Inventor: Hans O. Ribi
  • Patent number: 5340715
    Abstract: An evanescent wave sensor and method for use in analyzing one or more media, the sensor including a waveguide having first and second wave propagating surfaces. The waveguide propagates an input signal along the waveguide between the first and second surfaces. The first surface receives a first radiation signal which indicates the presence of a first analyte, and the second surface receives a second radiation signal representing one or both of a second analyte and a reference. The first and second surfaces can both be contacted with a single medium, or with two separate media, and one or more output signals can be detected.
    Type: Grant
    Filed: June 7, 1991
    Date of Patent: August 23, 1994
    Assignee: Ciba Corning Diagnostics Corp.
    Inventors: Rudolf E. Slovacek, Walter F. Love, Thomas A. Cook, Richard L. Schulkind, Irene M. Walczak
  • Patent number: 5331092
    Abstract: A process of preparation of collagen containing in major proportion insoluble collagen is disclosed, including rinsing and washing the collagenic tissue, acidifying the ground material pH value 1 to 4 to get a collagenic paste which is diluted in a diluting solution to get the collagen gel having a concentration in collagen lower than about 2.5 by weight expressed in dry collagen, and performing a shearing stirring at high speed producing ultrasonic effect to get a substantially homogeneous collagenic gel. The collagen has improved mechanical resistance and thermal stability.
    Type: Grant
    Filed: November 6, 1992
    Date of Patent: July 19, 1994
    Assignee: Coletica
    Inventors: Alain Huc, Rene Gimeno
  • Patent number: 5324649
    Abstract: A granular enzyme composition is produced, having reduced tendencies to form dust and leave residue, and exhibiting improved stability and delayed release characteristics. The granular composition comprises a core, an enzyme layer and an outer coating layer. The enzyme layer, and optionally the core and outer coating layer, contain a vinyl polymer. The vinyl polymer is preferably a hydrolyzed polyvinyl alcohol or copolymer thereof. The hydrolyzed polyvinyl alcohol has varying degrees of hydrolysis in the core, enzyme layer and outer coating layer. Also disclosed are methods for making such enzyme-containing granules, the methods having greatly reduced processing time.
    Type: Grant
    Filed: October 7, 1992
    Date of Patent: June 28, 1994
    Assignee: Genencor International, Inc.
    Inventors: Raymond E. Arnold, Nathaniel T. Becker, Matthew G. Boston, Aino Mansikkamaki, Curran M. Simpson, Daniel J. Wendt
  • Patent number: 5318903
    Abstract: A process for the production of dry, free-flowing, enzyme preparations by spraying aqueous enzyme dispersions, which may contain additives, in a spraying apparatus, which comprises the enzyme dispersion being sprayed in the presence of from 5 to 60% by weight, based on the content of enzyme in the dispersion, of a spray auxiliary composed of hydrophobic silica and/or a metal salt of a higher fatty acid at from 0.degree. to 50.degree. C., and drying the resulting particles loaded with spray auxiliary.
    Type: Grant
    Filed: June 4, 1992
    Date of Patent: June 7, 1994
    Assignee: BASF Aktiengesellschaft
    Inventors: Wolfgang Bewert, Gerhard Schwarz
  • Patent number: 5316927
    Abstract: A process for the production of high purity monoglycerides by lipase-catalyzed transesterification, and the products of the reaction, are described. In the method of the present invention, oils or pure triglycerides are combined with alcohol, a small amount of water and a lipase. The reaction proceeds under mild conditions, and produces high yields of .beta.-monoglyceride product.
    Type: Grant
    Filed: September 9, 1992
    Date of Patent: May 31, 1994
    Assignee: Opta Food Ingredients, Inc.
    Inventors: Aleksey Zaks, Akiva T. Gross
  • Patent number: 5300564
    Abstract: A method is proposed of obtaining a chemical interaction between at least one reagent trapped in sol-gel glass by doping it with the reagent, and diffusible solutes or components in an adjacent liquid or gas phase. The reagents, the solutes or the components can be any organic or inorganic compounds or materials of biological origin including enzymes. The doped sol-gel glass in various forms may be useful as analytical test, chromatographic medium, sensor, catalyst or biocatalyst, electrode or enzyme electrode, or other detection device.
    Type: Grant
    Filed: January 8, 1991
    Date of Patent: April 5, 1994
    Assignee: YISSUM, Research Development Company of the Hebrew University of Jerusalem
    Inventors: David Avnir, Michael Ottolenghi, Sergei Braun, Rivka Zusman
  • Patent number: 5292801
    Abstract: A method is proposed of obtaining a chemical interaction between at least one reagent trapped in sol-gel glass by doping it with the reagent, and diffusible solutes or components in an adjacent liquid or gas phase. The reagents, the solutes or the components can be any organic or inorganic compounds or materials of biological origin including enzymes. The doped sol-gel glass in various forms may be useful as analytical test, chromatographic medium, sensor, catalyst or biocatalyst, electrode or enzyme electrode, or other detection device.
    Type: Grant
    Filed: August 31, 1992
    Date of Patent: March 8, 1994
    Assignee: YISSUM, Research Development Company of the Hebrew University of Jerusalem
    Inventors: David Avnir, Michael Ottolenghi, Sergei Braun, Riyka Zusman
  • Patent number: 5290692
    Abstract: A fibrinolytic enzyme such as urokinase, tissue plasminogen activator or streptokinase is covalently bounded to a bioadaptable porous crystalline glass to produce a thrombolytic material. Production of the glass involves combining 40-50 mol% calcium oxide, 20-30 mol% titanium dioxide and 25-35 mol% diphosphorous pentoxide to form a mixture, and combining the mixture with 0.5-4.0 mol% disodium oxide. A bioreactor for converting plasminogen in blood into plasmin can be prepared by packing the material in a column. When finely comminuted, the material can be administered into the blood of a patient for removing blood clots.
    Type: Grant
    Filed: March 17, 1992
    Date of Patent: March 1, 1994
    Assignee: Agency of Industrial Science & Technology, Ministry of International Trade & Industry
    Inventors: Takahiro Suzuki, Sukezo Kawamura, Motohiro Toriyama, Yoshiyuki Yokogawa, Yukari Kawamoto
  • Patent number: 5290683
    Abstract: An assay for directly and rapidly determining the alcohol concentration of a lower alcohol in a biological fluid without dilution, comprises a solid carrier. The carrier is impregnated with a solution having the following constituents mixed in effective amounts: a cross-linked stabilized enzyme for oxidizing the alcohol in the presence of a reducible compound to produce a corresponding aldehyde and a reduction product, a chromogen which reacts with the reduction product in the presence of an agent to produce a colored compound indicative of alcohol presence in the biological fluid, a competitive inhibitor of the enzyme, an agent for converting the chromogen to the colored compound, and a buffer to maintain the solution at a predetermined acidic pH.
    Type: Grant
    Filed: November 19, 1992
    Date of Patent: March 1, 1994
    Inventors: Yedy Israel, Bhushan Kapur, Guang-chou Tu
  • Patent number: 5284587
    Abstract: A bacteria-containing two component polymer gel is provided for solubilizing particulate or colloidal organic materials in wastewater. The gel contains a minor amount of a polymer component that is difficult to solubilize by bacteria in the gel and a major amount of a polymer component that is easier to solubilize by bacteria in the gel. The gel contains bacteria for solubilizing material in wastewater and for solubilizing the gel, and nutrients for the bacteria. The gel also contains a bacteria inhibitor such as sodium sulfide or sodium azide that can diffuse out of the gel at a gel-water interface to allow bacteria to dissolve the gel at the interface while preventing an interior region of the gel from prematurely dissolving. The gel is placed in a housing through which wastewater flows and contacts the gel.
    Type: Grant
    Filed: December 20, 1991
    Date of Patent: February 8, 1994
    Assignee: General Environmental Science
    Inventors: John M. Wong, Thomas J. Lowe, Therese J. Schleiden
  • Patent number: 5283182
    Abstract: An immobilised hydantoinase containing a divalent metal ion selected from Mn.sup.++, Co.sup.++, Fe.sup.++, Ni.sup.++ and Mg.sup.++ is produced that is useful for the preparation of a D(-)(optionally substituted phenyl)glycine or N-carbamoyl derivative thereof by hydrolysis of a 5-(optionally substituted phenyl)hydantoin in the absence of air. Immobilization is carried out in the presence of the metal iona nd the metal ion stabilizes the hydantoinase and renders it capable of repeated re-use. The divalent metal ion may also be added to a reaction mixture containing the immobilized hydantoinase to minimize reduction of hydantoinase activity during hydrolysis of hydantoin. Cells that produce hydantoinase may be immobilized within or on a support, or hydantoinase separated from cells can be adsorbed on a positively charged polymeric support such as an ion exchange resin or covalently bonded to a polymeric support. A cross-linking agent such as glutaraldehyde may be used in immobilization.
    Type: Grant
    Filed: February 28, 1990
    Date of Patent: February 1, 1994
    Assignee: Beecham Group PLC
    Inventors: Lawson W. Powell, John A. Power
  • Patent number: 5279954
    Abstract: The invention provides a means for attaching a label, support or bioactive agent to a protein with an exopeptidase at a site that is remote from the active site of the protein. More specifically the invention is directed to a method for the attachment of an amino acid, amine and alcohol nucleophile to the carboxyl terminus of a protein. In one embodiment, a labeled nucleophile is attached to a protein such as an antibody. In other embodiments, the invention is directed to a method for the attachment of a protein to an immobilization support and to a method for the attachment of a bioactive agent to a protein.
    Type: Grant
    Filed: June 30, 1989
    Date of Patent: January 18, 1994
    Assignee: Board of Regents of the University of Nebraska and BioNebraska
    Inventors: Fred W. Wagner, Thomas R. Coolidge, Dwane E. Wylie, Sheldon M. Schuster, William Lewis, Jay Stout
  • Patent number: 5272087
    Abstract: An enzymatic electrode, having a homogeneous composition throughout, consists essentially of a uniform intimate admixture of a conducting powder with at least one immobilized enzyme, or with an immobilized enzyme and a mediator agent or a co-enzyme, in a matrix. The electrode is one which has a surface available for direct contact with a substrate without a permeable or semi-permeable intermediate membrane or membranes. The enzymatic electrode is prepared, e.g., by intimately admixing (a) a homogeneous paste or matrix (resulting from an intimate admixture of a conducting powder with a binder), (b) at least one enzyme and (c) an enzyme crosslinking solution, and then incorporating therein a mediator agent and/or a co-enzyme.
    Type: Grant
    Filed: October 16, 1990
    Date of Patent: December 21, 1993
    Assignee: Centre National de la Recherche Scientifique (C.N.R.S.)
    Inventors: Nabil El Murr, Mohamed Slilam
  • Patent number: 5270192
    Abstract: Disclosed is a hepatocyte bioreactor or bioartificial liver which comprises a containment vessel having a perfusion inlet and a perfusion outlet; a matrix within the containment vessel so as to entrap hepatocyte aggregates within the containment vessel while allowing perfusion of the matrix. The invention is useful as an artificial liver.
    Type: Grant
    Filed: February 7, 1991
    Date of Patent: December 14, 1993
    Assignee: Monsanto Company
    Inventors: Albert Pak-Hung Li, Timothy D. Whitehead, Dale J. Beck, George E. Barker
  • Patent number: 5268271
    Abstract: Synthesis of semi-synthetic monobactamic or .beta.-Lactamic antibiotics by using derivatives stabilized by various methods of penicillin G acylase from various microbial sources according to a thermodynamically controlled strategy in monophase water/cosolvent organic apolar systems, wherein the concentration of the cosolvent varies between 30% and 90%, the temperature between -10.degree. C. and 50.degree. C., the pH between 4.5 and 8.5, with concentrations of the antibiotic nucleus between 0.5 an 875 mM and acyl donor between 0.2 mM and 1M, with a relationship antibiotic ring/activated or free acyl donor, using a buffer between 0 and 1M. Application to the pharmaceutical industry.
    Type: Grant
    Filed: August 2, 1991
    Date of Patent: December 7, 1993
    Assignee: Cosejo Superior de Invetigaciones Certificas
    Inventors: Jose M. Guisan Seijas, Roberto Fernandez Lafuente, Gregorio Alvaro Campos, Rosa M. Blanco Martin, Cristina Molina Rosell
  • Patent number: 5268306
    Abstract: A specific binding pair is bound to an insoluble carrier for use in determining an analyte such as in an immunoassay. The carrier is coated with a first polymer containing a protein polymer having a molecular weight of at least about 20,000 and molecules of a first member of a specific binding pair. A second polymer containing a second member of the specific binding pair is bound to the first member on the carrier by binding of the first and second members of the specific binding pair. The first polymer is preferably more hydrophobic than the second polymer. The protein polymer can be prepared by cross-linking hydrophobic protein molecules of 10,000 to 700,000 molecular weight with a bifunctional or polyfunctional compound to obtain a protein polymer of 200,000 to 20,000,000 molecular weight. The second polymer can be the second member of the specific binding pair or the second member cross-linked with a linker or the second member cross-linked to a hydrophobic protein.
    Type: Grant
    Filed: December 23, 1991
    Date of Patent: December 7, 1993
    Assignee: Boehringer Mannheim GmbH
    Inventors: Michael Berger, Arno Deger, Josef Maier
  • Patent number: 5264359
    Abstract: A method for the large-scale cultivation of animal cells wherein animal cells are embedded in a collagen gel which is covered by a protective coating. The protective coating supports and protects the collagen matrix.
    Type: Grant
    Filed: December 11, 1989
    Date of Patent: November 23, 1993
    Assignee: Nitta Gelatin Inc.
    Inventors: Junpei Enami, Naohito Kondo, Toshikazu Takano, Kaneo Suzuki
  • Patent number: 5264129
    Abstract: A filter device for use in the treatment of water to render it potable, which is of particular value in emergency situations, comprises exo-polysaccharide producing, gram-negative bacteria supported upon a water-permeable material which is non-toxic to microorganisms and to human beings, is resistant to temperatures within the range from -15.degree. C. to +65.degree. C., and is not readily biodegradable. The device may be freeze-dried to enable it to be stored until it is required for use and may then be reactivated by the addition of water. It may be used as the surface layer in a slow-sand filter.
    Type: Grant
    Filed: February 25, 1993
    Date of Patent: November 23, 1993
    Assignee: Biofil Limited
    Inventors: James R. Simpson, Martin R. Tucker
  • Patent number: 5260211
    Abstract: A process and system for cultivating adhesive cells in a packed bed of solid cell matrix is disclosed. Adhesive cells are adhered to a solid cell matrix, preferably ceramic particles, and packed in a cell culture tank to form the packed bed. The culture medium is circulated through the packed bed in a direction. The circulating of the culture medium is then stopped and the direction of the medium being circulated is reversed. This periodic switching of the direction of the culture medium reduces channelling of the culture medium. The bottom or head of the culture tank can also contain a separator to trap any bubble existing in the culture medium or to trap any quantity of cell matrix possibly running out from the culture tank.
    Type: Grant
    Filed: November 26, 1990
    Date of Patent: November 9, 1993
    Assignee: Snow Brand Milk Products Co., Ltd.
    Inventors: Yoshiaki Matsuda, Shinjiro Mitsuda, Eitaro Kumazawa, Atushi Baba, Masakatsu Uesaka
  • Patent number: 5256271
    Abstract: A microbioelectrode having high performance produced by immobilization by incorporating a biologically active substance in the interior or on the surface of a porous conductive material layer or fine particle layer which has been deposited on the surface of a transducing material. The inventive microbioelectrode demonstrates sufficient output even if the sensor using the electrode is very small in size.
    Type: Grant
    Filed: June 17, 1992
    Date of Patent: October 26, 1993
    Assignees: Japan as represented by President of National Rehabilitation, Sumitomo Cement Co., Ltd.
    Inventors: Yoshihito Ikariyama, Shigeru Yamauchi, Tomoaki Yukiashi
  • Patent number: 5246846
    Abstract: Reactants containing amino, mercapto or hydroxy groups such as proteins, peptides, ligands, coenzymes or enzymes are immobilized on a support containing amino, mercapto or hydroxy groups by coupling the reactant to the support with a compound having the following formula (I) or (IA): ##STR1## wherein X is a halogen and R.sub.1, R.sub.2 are the same or different and are X, R, COR, COOR, wherein R is C.sub.1 -C.sub.8 alkyl, COOH, CNS, N.sub.3 or CN. The support may be first reacted with the compound to produce a derivatized support which is then reacted the reactant or the reactant may be first reacted with the compound and the resultant product then reacted with the support. An electrochemical biosensor can be prepared by using a conductive support.
    Type: Grant
    Filed: December 31, 1990
    Date of Patent: September 21, 1993
    Inventors: Fritz Pittner, Thomas Schalkhammer, Gerald Urban, Eva Mann-Buxbaum
  • Patent number: 5244807
    Abstract: A culture of Pseudomonas XA cells containing indolyl-3-alkane alpha-hydroxylase(INDH) is produced by aerobic batch fermentation in a culture medium. The culture medium is in a vessel having a means for adjusting agitation rate. During culturing, the cells go through a logarithmic phase and a stationary phase. Oxygen concentration is measured in the culture medium at the beginning of the process to determine a first oxygen concentration. Agitation rate is adjusted to produce a second oxygen concentration in the culture medium of about two to about seven percent of the first oxygen concentration for a time period of about two to about seven hours which ends at the beginning of the stationary phase. An INDH having three subunits of different molecular weight is isolated from the cells. The INDH is stable, free from endotoxin-mediated side effects and has sufficient specific activity to be useful for depletion of tryptophan from aqueous solution. During use, the INDH may be in immobilized form.
    Type: Grant
    Filed: May 23, 1990
    Date of Patent: September 14, 1993
    Assignee: Automedix Sciences, Inc.
    Inventors: Robert L. Murtfeldt, Allan J. Bream, Kathryn K. McCarthy
  • Patent number: 5242964
    Abstract: A process for the preparation of aqueous dispersions of magnetizable polymer particles with a narrow distribution from aqueous dispersions with a wide distribution. The amount of water in the aqueous dispersion with a wide distribution is adjusted so that the proportion by weight of magnetizable polymer particles is between about 1 and 40% of said dispersion. The surfactant concentration of the dispersion after the water adjustment is increased until two phases are obtained: a so-called liquid phase and a so-called solid phase. After separation of these two phases is accomplished, these steps are repeated as desired. An aqueous dispersion with a narrow size distribution is recovered.
    Type: Grant
    Filed: July 29, 1991
    Date of Patent: September 7, 1993
    Assignee: Rhone-Poulenc Chimie
    Inventors: Jerome Bibette, Dominique Charmot, Gilbert Schorsch
  • Patent number: 5234991
    Abstract: A porous mineral support such as a porous mineral oxide coated with an aminated polysaccharide polymer has cationic characteristics and is capable of reversibly fixing thereto biological macromolecules. This material is employed in the separation and purification of said biologic macromolecules.
    Type: Grant
    Filed: March 17, 1987
    Date of Patent: August 10, 1993
    Assignee: Pasteur Merieux Serums and Vaccines
    Inventors: Jean-Louis Tayot, Michel Tardy